Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash-to-Debt 0.05
CYH's Cash-to-Debt is ranked lower than
86% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 0.37 vs. CYH: 0.05 )
Ranked among companies with meaningful Cash-to-Debt only.
CYH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: 0.15
Current: 0.05
0
0.15
Equity-to-Asset 0.06
CYH's Equity-to-Asset is ranked lower than
93% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. CYH: 0.06 )
Ranked among companies with meaningful Equity-to-Asset only.
CYH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.06  Med: 0.16 Max: 0.46
Current: 0.06
0.06
0.46
Debt-to-Equity 11.36
CYH's Debt-to-Equity is ranked lower than
98% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 0.63 vs. CYH: 11.36 )
Ranked among companies with meaningful Debt-to-Equity only.
CYH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.87  Med: 3.6 Max: 11.36
Current: 11.36
0.87
11.36
Debt-to-EBITDA 9.76
CYH's Debt-to-EBITDA is ranked lower than
89% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 2.82 vs. CYH: 9.76 )
Ranked among companies with meaningful Debt-to-EBITDA only.
CYH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 4.98  Med: 5.72 Max: 42.23
Current: 9.76
4.98
42.23
Interest Coverage 0.43
CYH's Interest Coverage is ranked lower than
97% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 7.55 vs. CYH: 0.43 )
Ranked among companies with meaningful Interest Coverage only.
CYH' s Interest Coverage Range Over the Past 10 Years
Min: 0.43  Med: 1.49 Max: 1.97
Current: 0.43
0.43
1.97
Piotroski F-Score: 5
Altman Z-Score: 1.03
Beneish M-Score: -2.90
WACC vs ROIC
5.29%
2.17%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 2.32
CYH's Operating Margin % is ranked lower than
72% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. CYH: 2.32 )
Ranked among companies with meaningful Operating Margin % only.
CYH' s Operating Margin % Range Over the Past 10 Years
Min: -4.66  Med: 8.03 Max: 9.55
Current: 2.32
-4.66
9.55
Net Margin % -3.64
CYH's Net Margin % is ranked lower than
81% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 4.16 vs. CYH: -3.64 )
Ranked among companies with meaningful Net Margin % only.
CYH' s Net Margin % Range Over the Past 10 Years
Min: -9.33  Med: 1.4 Max: 2.22
Current: -3.64
-9.33
2.22
ROE % -39.46
CYH's ROE % is ranked lower than
92% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. CYH: -39.46 )
Ranked among companies with meaningful ROE % only.
CYH' s ROE % Range Over the Past 10 Years
Min: -61.09  Med: 6.84 Max: 13.65
Current: -39.46
-61.09
13.65
ROA % -2.91
CYH's ROA % is ranked lower than
81% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.45 vs. CYH: -2.91 )
Ranked among companies with meaningful ROA % only.
CYH' s ROA % Range Over the Past 10 Years
Min: -7.09  Med: 1.1 Max: 1.95
Current: -2.91
-7.09
1.95
ROC (Joel Greenblatt) % 5.18
CYH's ROC (Joel Greenblatt) % is ranked lower than
72% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 14.51 vs. CYH: 5.18 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CYH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -6.6  Med: 13.81 Max: 16.24
Current: 5.18
-6.6
16.24
3-Year Revenue Growth Rate 6.80
CYH's 3-Year Revenue Growth Rate is ranked lower than
54% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. CYH: 6.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CYH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0.2  Med: 11 Max: 47.2
Current: 6.8
0.2
47.2
3-Year EBITDA Growth Rate -43.50
CYH's 3-Year EBITDA Growth Rate is ranked lower than
92% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. CYH: -43.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CYH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -43.5  Med: 6.6 Max: 45.2
Current: -43.5
-43.5
45.2
GuruFocus has detected 4 Warning Signs with Community Health Systems Inc CYH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CYH's 30-Y Financials

Financials (Next Earnings Date: 2017-11-01)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

CYH Guru Trades in Q3 2016

Joel Greenblatt 314,386 sh (New)
Barrow, Hanley, Mewhinney & Strauss 199,956 sh (New)
Steven Cohen 1,299,500 sh (New)
Ray Dalio 23,400 sh (New)
David Dreman 566 sh (unchged)
Ron Baron 100 sh (unchged)
John Paulson 1,275,000 sh (unchged)
David Einhorn Sold Out
David Tepper Sold Out
Jeremy Grantham Sold Out
Ronald Muhlenkamp 375,380 sh (-0.49%)
Jeff Auxier 25,894 sh (-0.92%)
Richard Snow 654,132 sh (-82.74%)
» More
Q4 2016

CYH Guru Trades in Q4 2016

Chuck Royce 1,887,695 sh (New)
Paul Tudor Jones 20,200 sh (New)
Jim Simons 1,576,052 sh (New)
Paul Singer 1,825,000 sh (New)
Barrow, Hanley, Mewhinney & Strauss 430,326 sh (+115.21%)
Joel Greenblatt 627,092 sh (+99.47%)
David Dreman 566 sh (unchged)
Ron Baron 100 sh (unchged)
John Paulson 1,600,000 sh (unchged)
Richard Snow Sold Out
Jeff Auxier Sold Out
Ray Dalio Sold Out
Ronald Muhlenkamp 372,415 sh (-0.79%)
Steven Cohen 323,500 sh (-75.11%)
» More
Q1 2017

CYH Guru Trades in Q1 2017

Steven Cohen 1,344,100 sh (+315.49%)
Chuck Royce 2,181,495 sh (+15.56%)
Barrow, Hanley, Mewhinney & Strauss 445,085 sh (+3.43%)
Ron Baron 100 sh (unchged)
John Paulson 340,000 sh (unchged)
David Dreman Sold Out
Ronald Muhlenkamp Sold Out
Paul Tudor Jones Sold Out
Jim Simons Sold Out
Paul Singer Sold Out
Joel Greenblatt 475,052 sh (-24.25%)
» More
Q2 2017

CYH Guru Trades in Q2 2017

Jim Simons 487,493 sh (New)
Joel Greenblatt 963,388 sh (+102.80%)
Chuck Royce 2,255,795 sh (+3.41%)
Barrow, Hanley, Mewhinney & Strauss 445,085 sh (unchged)
Ron Baron 100 sh (unchged)
John Paulson 340,000 sh (unchged)
Steven Cohen Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with CYH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2017-06-30 Add 102.80%0.07%$8.24 - $10.32 $ 6.44-30%963,388
Joel Greenblatt 2017-03-31 Reduce -24.25%0.01%$5.81 - $9.86 $ 6.44-17%475,052
Barrow, Hanley, Mewhinney & Strauss 2017-03-31 Add 3.43%$5.81 - $9.86 $ 6.44-17%445,085
David Dreman 2017-03-31 Sold Out $5.81 - $9.86 $ 6.44-17%0
Ronald Muhlenkamp 2017-03-31 Sold Out 0.66%$5.81 - $9.86 $ 6.44-17%0
Joel Greenblatt 2016-12-31 Add 99.47%0.02%$4.66 - $11.47 $ 6.44-7%627,092
Barrow, Hanley, Mewhinney & Strauss 2016-12-31 Add 115.21%$4.66 - $11.47 $ 6.44-7%430,326
Ronald Muhlenkamp 2016-12-31 Reduce -0.79%0.01%$4.66 - $11.47 $ 6.44-7%372,415
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:BKK:CHG-F, OSTO:CAPIO, XSWX:AEVS, LSE:MDMG, NYSE:USPH, NSE:NH, ISX:SILO, NAS:PRSC, NAS:AFAM, XKLS:5878, TSE:9792, BKK:RAM, HKSE:03886, BKK:VIBHA, SAU:4007, SGX:5G3, BKK:BCH-F, NSE:MAXINDIA, TSE:6197, BKK:SVH » details
Traded in other countries:CG5.Germany,
Headquarter Location:USA
Community Health Systems Inc is a operators of general acute care hospitals. The company organizes into two distinct operating segments, Hospital Operations and Home Care Agency Operations.

Community Health Systems is the largest publicly owned hospital operator in the United States. The company owns or leases 118 general acute-care hospitals located in nonurban and urban markets. The company also owns four home health agencies and provides management and consulting services to independent hospitals.

Guru Investment Theses on Community Health Systems Inc

Baron Funds Comments on Community Health Systems - Feb 05, 2016

Shares of hospital operator Community Health Systems, Inc. (NYSE:CYH) fell in the fourth quarter on an earnings miss driven by lower volumes and deteriorating payor mix. Concerns that the Affordable Care Act tailwind is largely over and leveraged companies will be hurt by rising interest rates also brought out sellers. We think the spinoff of Quorum Health will create value, HMA synergies will exceed initial guidance, record numbers of recruited doctors will boost admissions, more states will expand Medicaid, and deleveraging will strengthen the balance sheet. (Susan Robbins)



From Ron Baron (Trades, Portfolio)'s Growth Fund fourth quarter shareholder letter.

Check out Ron Baron latest stock trades

Baron Funds Comments on Community Health Systems Inc. - Nov 10, 2015

Community Health Systems Inc. (NYSE:CYH) is one of the country’s largest hospital operators, with 31,000 beds in 29 states, primarily located in small and midsized markets. Shares were weak on concerns that Affordable Care Act tailwinds are largely over and that comps will be more difficult going forward. We maintain a positive view as we believe the spinoff of Quorum Health will create shareholder value, synergies from the merger with HMA will exceed initial guidance, more states will expand Medicaid, and deleveraging will accelerate. (Susan Robbins)



From Baron Growth Fund's third quarter 2015 letter.



Check out Ron Baron latest stock trades

Top Ranked Articles about Community Health Systems Inc

Community Health Systems To Broadcast Third Quarter 2017 Conference Call Live On The Internet
Almost Family, Inc. to Present at the Baird 2017 Global Healthcare Conference
Almost Family, Inc. to Report Second Quarter 2017 Financial Results After Market Close on August 8, 2017
Community Health Systems To Broadcast Second Quarter 2017 Conference Call Live On The Internet
Almost Family, Inc. to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
Almost Family, Inc. to Report First Quarter 2017 Financial Results After Market Close on May 9, 2017
Community Health Systems to Broadcast First Quarter 2017 Conference Call Live On the Internet
Analysts Release New Health Care Stock Ratings Jeffries downgrades Amgen to hold from buy
Analysts released new ratings for some health care stocks recently. Read more...
Community Health Systems to Broadcast Fourth Quarter and Year-End 2016 Conference Call Live on the Internet

FRANKLIN, Tenn., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Community Health Systems, Inc. (NYSE:NYSE:CYH) today announced that it will provide an online Web simulcast and rebroadcast of its fourth quarter and year-end 2016 conference call. The Company will issue a press release announcing its results in the afternoon on Monday, February 20, 2017. The conference call is scheduled to begin at 10:00 a.m. Central time, 11:00 a.m. Eastern time, on Tuesday, February 21, 2017. A live broadcast of the conference call will be available online at
www.chs.net
. To listen to the live call, please go to the web site at least 15 minutes early to register, download, and install any necessary audio software. The online replay will follow shortly after the call and continue through March 21, 2017. During this call, Community Health Systems will review the Company’s financial and operating results for the fourth quarter and year ended December 31, 2016. About Community Health Systems, Inc.

Community Health Systems, Inc. is one of the largest publicly traded hospital companies in the United States and a leading operator of general acute care hospitals in communities across the country. The Company, through its subsidiaries, owns, leases or operates 158 affiliated hospitals in 22 states with an aggregate of nearly 27,000 licensed beds. The Company’s headquarters are located in Franklin, Tennessee, a suburb south of Nashville. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol “CYH.” More information about the Company can be found on its website at

www.chs.net
.

Investor Contacts:
W. Larry Cash
President of Financial Services and Chief Financial Officer
(615) 465-7000
or
Ross W. Comeaux
Senior Director – Investor Relations
(615) 465-7012


Read more...
Almost Family Sells 450,000 Additional Shares Of Common Stock Pursuant To Underwriters' Over-Allotment Option

LOUISVILLE, Ky., Jan. 20, 2017 (GLOBE NEWSWIRE) -- Almost Family, Inc. (NASDAQ:AFAM) announced today that the underwriters of its recent public offering of common stock have exercised their over-allotment option to purchase an additional 450,000 shares, bringing the total number of shares sold in the offering of common stock to 3,450,000 shares and total gross proceeds to approximately $153.5 million. Total net proceeds of the offering to Almost Family, after deducting underwriting discounts and commissions and other estimated offering expenses payable by Almost Family, will be approximately $144.3 million. The closing of the sale of the additional shares of common stock pursuant to the exercise of the over-allotment option is expected to close on or about January 25, 2017, along with the closing of the common stock offering.
J.P. Morgan Securities LLC and BofA Merrill Lynch are acting as joint book‑running managers for the offering. Capital One Securities, Inc., Fifth Third Securities, Inc. and Regions Securities LLC are acting as co-managers for the offering. The offering is being made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission (“SEC”). The offering will be made only by means of a prospectus supplement and the accompanying base prospectus, copies of which may be obtained by contacting (i) J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewater, NY 11717, or telephone: 866-803-9204 or (ii) BofA Merrill Lynch, NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte NC  28255-0001, Attn: Prospectus Department, or Email: [email protected]. These documents have been filed with the SEC and are available at the SEC’s website at http://www.sec.gov. This press release shall not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of any such state or jurisdiction. Forward Looking Statements This press release contains forward-looking statements within the meaning of the federal securities laws, including statements related to the offering and the expected use of the net proceeds. These forward-looking statements are based on current plans, expectations, projections, forecasts and assumptions about future events that involve risks and uncertainties that could cause actual outcomes and results to differ materially. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by the use of forward-looking terminology such as “may,” “will,” “should,” “could,” “would,” “estimate,” “project,” “forecast,” “intend,” “expect,” “plan,” “anticipate,” “believe,” “target,” or similar terms, variations of those terms or the negative of those terms. While forward-looking statements reflect good faith beliefs, assumptions and expectations, they are not guarantees of future performance, and the Company undertakes no obligation to update or revise its forward-looking statements. The forward-looking statements in this news release are based on a variety of assumptions that may not be realized and that are subject to significant risks and uncertainties, including that the offering may not be completed. For a more complete discussion regarding other factors which could affect the Company's financial performance, refer to the Company's various filings with the Securities and Exchange Commission, including its filing on Form 10-K for the year ended January 1, 2016, in particular information under the headings "Special Caution Regarding Forward-Looking Statements" and “Risk Factors.” About Almost Family, Inc. Almost Family, Inc., founded in 1976, is a leading national provider of home healthcare services, with 340 branch locations in 26 states, following the completion of its joint venture transaction with Community Health Systems, Inc. (CHS) (NYSE:NYSE:CYH). Almost Family, Inc. and its subsidiaries operate a visiting nurse segment, a personal care segment and a HealthCare Innovations segment. CHS Home Health, the joint venture with CHS, is one of the nation’s larger Medicare home health care providers with 74 home health and 15 hospice locations in 22 states. Most of its home health and hospice operations are affiliated with CHS general acute care hospitals in communities across the country. The JV is managed by Almost Family, governed by a board with proportionate representation from Almost Family and CHS and is primarily focused on serving the post-acute home health needs of the current CHS locations while also developing additional home health capabilities in communities with a CHS hospital but no affiliated home healthcare.  

Almost Family, Inc.
Steve Guenthner
(502) 891-1000

Read more...

Ratios

vs
industry
vs
history
Forward PE Ratio 30.96
CYH's Forward PE Ratio is ranked lower than
93% of the 58 Companies
in the Global Medical Care industry.

( Industry Median: 19.88 vs. CYH: 30.96 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 0.60
CYH's PB Ratio is ranked higher than
96% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 2.62 vs. CYH: 0.60 )
Ranked among companies with meaningful PB Ratio only.
CYH' s PB Ratio Range Over the Past 10 Years
Min: 0.3  Med: 1.11 Max: 1.85
Current: 0.6
0.3
1.85
PS Ratio 0.04
CYH's PS Ratio is ranked higher than
99% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. CYH: 0.04 )
Ranked among companies with meaningful PS Ratio only.
CYH' s PS Ratio Range Over the Past 10 Years
Min: 0.03  Med: 0.21 Max: 0.74
Current: 0.04
0.03
0.74
Price-to-Free-Cash-Flow 1.86
CYH's Price-to-Free-Cash-Flow is ranked higher than
98% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: 22.48 vs. CYH: 1.86 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CYH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0.12  Med: 7.41 Max: 77.96
Current: 1.86
0.12
77.96
Price-to-Operating-Cash-Flow 0.72
CYH's Price-to-Operating-Cash-Flow is ranked higher than
99% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 14.62 vs. CYH: 0.72 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CYH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.49  Med: 2.34 Max: 9.29
Current: 0.72
0.49
9.29
EV-to-EBIT 28.17
CYH's EV-to-EBIT is ranked lower than
69% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 20.85 vs. CYH: 28.17 )
Ranked among companies with meaningful EV-to-EBIT only.
CYH' s EV-to-EBIT Range Over the Past 10 Years
Min: -31.8  Med: 11.6 Max: 28.9
Current: 28.17
-31.8
28.9
EV-to-EBITDA 9.77
CYH's EV-to-EBITDA is ranked higher than
76% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 15.17 vs. CYH: 9.77 )
Ranked among companies with meaningful EV-to-EBITDA only.
CYH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.4  Med: 7.4 Max: 213.7
Current: 9.77
5.4
213.7
EV-to-Revenue 0.84
CYH's EV-to-Revenue is ranked higher than
84% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 2.18 vs. CYH: 0.84 )
Ranked among companies with meaningful EV-to-Revenue only.
CYH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.8  Med: 1 Max: 2.1
Current: 0.84
0.8
2.1
Current Ratio 2.13
CYH's Current Ratio is ranked higher than
72% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.41 vs. CYH: 2.13 )
Ranked among companies with meaningful Current Ratio only.
CYH' s Current Ratio Range Over the Past 10 Years
Min: 1.28  Med: 1.75 Max: 2.34
Current: 2.13
1.28
2.34
Quick Ratio 1.94
CYH's Quick Ratio is ranked higher than
72% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.31 vs. CYH: 1.94 )
Ranked among companies with meaningful Quick Ratio only.
CYH' s Quick Ratio Range Over the Past 10 Years
Min: 1.14  Med: 1.56 Max: 2.14
Current: 1.94
1.14
2.14
Days Inventory 61.19
CYH's Days Inventory is ranked lower than
83% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 16.86 vs. CYH: 61.19 )
Ranked among companies with meaningful Days Inventory only.
CYH' s Days Inventory Range Over the Past 10 Years
Min: 17.9  Med: 65.29 Max: 68.3
Current: 61.19
17.9
68.3
Days Sales Outstanding 61.37
CYH's Days Sales Outstanding is ranked lower than
74% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 41.26 vs. CYH: 61.37 )
Ranked among companies with meaningful Days Sales Outstanding only.
CYH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.58  Med: 60.84 Max: 78.9
Current: 61.37
49.58
78.9
Days Payable 115.46
CYH's Days Payable is ranked higher than
72% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: 51.14 vs. CYH: 115.46 )
Ranked among companies with meaningful Days Payable only.
CYH' s Days Payable Range Over the Past 10 Years
Min: 46.88  Med: 138 Max: 175.38
Current: 115.46
46.88
175.38

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -6.20
CYH's 3-Year Average Share Buyback Ratio is ranked lower than
64% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. CYH: -6.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CYH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -21.9  Med: 0.3 Max: 3.8
Current: -6.2
-21.9
3.8

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.20
CYH's Price-to-Median-PS-Value is ranked higher than
98% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. CYH: 0.20 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CYH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.16  Med: 1.32 Max: 9.02
Current: 0.2
0.16
9.02
Earnings Yield (Greenblatt) % 3.57
CYH's Earnings Yield (Greenblatt) % is ranked lower than
54% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.79 vs. CYH: 3.57 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CYH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -6  Med: 7.9 Max: 12
Current: 3.57
-6
12
Forward Rate of Return (Yacktman) % -59.58
CYH's Forward Rate of Return (Yacktman) % is ranked lower than
100% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 8.93 vs. CYH: -59.58 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CYH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -61.1  Med: 16.4 Max: 84.5
Current: -59.58
-61.1
84.5

More Statistics

Revenue (TTM) (Mil) $17,479.00
EPS (TTM) $ -5.71
Beta1.46
Short Percentage of Float30.23%
52-Week Range $4.15 - 10.65
Shares Outstanding (Mil)114.76

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 17,751 16,580 17,872
EPS ($) -0.39 0.17 0.68
EPS without NRI ($) -0.39 0.17 0.68
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAN
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}